It has been known since 1893 that blood contains a proteolytic enzyme (1) and an inhibitor of this enzyme (2). Failure to detect any proteolytic activity in fresh serum was explained by the assumption that the enzyme was kept neutralized by an excess of the inhibitor. Such a protease-antiprotease system has attracted a great deal of attention because of the possibility that it is associated with certain immunological processes. Recent investigations have indicated that a proteolytic enzyme is present in serum as an inactive precursor which can be activated under certain circumstances. Such activation occurs when serum is treated with chloroform (3) or with a substance produced by certain strains of hemolytic streptococci (4). However, this does not explain the mechanism of fibrinolysis observed under various experimental (5) and clinical (6-8) conditions.
eliminate the inhibitor by adsorption, it was found that separation of the enzyme from itsinhibitor was obtained in the following manner. The activating agent, dissolved in physiological saline, was added to a measured amount of serum. After a measured duration of contact, the mixture was diluted with distilled water to twenty times the initial volume, adjusted to pH 5.2 with 0.5 per cent acetic acid by means of a glass electrode, and centrifuged. The supernatant, containing antiiibrinolysin, was discarded and the precipitate was redissolved in saline buffered to pH 7.4 (phosphate buffer diluted to 0.1 M with 0.9 per cent NaC1). In the control sample, saline was added to serum and the mixture submitted to identical treatment.
Guinea pig serum was used throughout the experiments. Individual blood samples were taken by heart puncture; pooled blood was collected by bleeding guinea pigs from the carotid and jugular vessels. The serum collected from clotted blood was stored between experiments at --20 °C. was used in most experiments. Suggested first by Ferguson (11) , the fibrinogenolytic method proved more sensitive than any other existing quantitative technique. It allowed the detection of amounts of enzyme equivalent to 10 ~ mg. crystalline trypsin and was about 36 times more sensitive than the clot-lysis method as used by Loomis (9) .
As described previously (10), the fibrinogenolytic method was standardized with crystalline trypsin. In the present work, the results are expressed in units obtained by comparison with the activity of a fibrinolysin preparation, t Fibrinogen submitted to the action of fibrinolysin loses its ability to clot on addition of thrombin. Duration of contact necessary to prevent clotting is inversely proportional to enzyme concentration when plotted on a logarithmic scale (Fig. 1) .
Amounts of 0.2 ml. of a 0.2 per cent solution of fibrinogen ~ (in buffered saline at pH 7.4) are pipetted into a series of small tubes. Varying amounts of the enzyme solution to be tested are added to the fibrinogen and the total volume is made up to 0.4 ml. with saline. After incubation at 37.5°C. for 30 minutes one drop of a thrombin solution 8 is added to each tube. The tube containing the lowest concentration of enzyme which fails to clot in 30 minutes contains by definition one unit of enzyme. In a previous publication (10) the unit was defined by the same duration of contact and at the same concentration of the reagents but the total volume was 5 ml. For purposes of comparison, aU readings obtained in the present experiments have been divided by 12.5.
Some of the results of the fibrinogenolytic technique were confirmed by a viscosimetric method. This was considered more suitable than turbidity measurements Used by Grob (12) and Ratnoff (13) because high turbidity of crude enzyme preparations interferes with the accurate reading of results. Two ml. of a 3 per cent solution of gelatin (in saline buffered to Fig. 2 shows that log X is linearly related to the logarithm of enzyme concentration for values of X between 2.5 and 25. The calibration curve was obtained with purified fibrinolysin. The results obtained by viscosimetry are also expressed in terms of the units defined above.
RESULTS
The hypothesis tested in the first series of experiments was that failure to detect fibrinolytic activity on addition of the specific antigen or peptone (10) to serum was due to the neutralization of the activated enzyme by antifibrinolysin. If this hypothesis proved true, neutralization should be prevented by precipitating the enzyme shortly after addition of the activating agent. Under these conditions enzyme activity could be detected in the euglobulin precipitate. The findings confirmed this hypothesis.
1. Anal~hylaxis.--Eight guinea pigs received one subcutaneous injection each of 10 mg. egg albumin? Twenty-five days after sensitization 1.5 ml. of blood was collected from each guinea pig by heart puncture. To each serum specimen 0.1 mg. per ml. egg albumin was added and after 3 minutes' contact, euglobulin was precipitated as described above. The precipitate was redissolved and fibrinolysin activity estimated by the fibrinogenolytic method. The results, summarized in Table I , show that the mean proteolytic activity of sera from sensitized guinea pigs treated with antigen was 1.9 units per ml.
(-4-0.3); whereas the same sera, untreated, gave the average value of less than 0.3 unit. When serum from normal, non-sensitized guinea pigs was mixed with egg albumin, there was no significant difference between albumin and saline-treated samples (0.19 and 0.14 respectively). These findings indicate d Soluble egg albumin Merck.
that the antigen-antibody reaction is accompanied by the conversion of inactive profibrinolysin into an active proteolytic enzyme.
2. Peptone.--The same results were observed when peptone 5 was added in dtro to normal guinea pig serum. As seen in Table II , the optimum amount of peptone is 20 mg. per ml. of serum. It is also seen that activity varies according to the interval between addition of peptone to serum and precipitation of euglobulin. Activity increases between 25 seconds and 1 minute and then decreases between 2 and 15 minutes. This suggests that the profibrinolysin activation is comparatively rapid and also that simultaneously with the acti- • cation the enzyme combines with antiiibrinolysin. After the first I or 2 minutes the rate of combination is faster than the activation which results in the gradual decrease of free enzyme. The results shown in Table II were obtained in pooled guinea pig serum. Experiments were also performed on samples from individual guinea pigs and Table III shows the variation in profibrinolysin activation observed in eight guinea pigs. When peptone was applied under optimum conditions of 20 rag. per ml. serum for 2 minutes, the average value of fibrinolysin released is 4.95 units per ml. (4-0.94). The variation, as estimated by the coefficient of variation, is 48.8 in anaphylaxis and 53.2 in the case of peptone.
s Proteose-peptone Difco 3. Agar.--It is known that the addition of agar induces changes in guinea pig serum. When injected into guinea pigs the altered serum kills the animals (14) . To determine whether the acquired toxicity was associated with the activation of profibrinolysin, the following experiment was done. Pooled guinea pig serum was mixed with varying amounts of a 0.5 per cent solution of agar 6 kept at 37°C. The mixture was shaken for 2 minutes and kept after- 
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Fibrinogenolytic method. Table IV indicate that agar activates fibrinolysin and the maximum activation is reached with 5 rag. per ml. serum.
4. HyaZuronic Acid.--Since agar proved to be an activating agent for profibrinolysin, other polysaccharides were tested and were also found to be active.
Nutrient agar Difco.
Among these, hyaluronic acid 7 was the most potent and constant in its effect. Table V shows the action of hyaluronic acid on four samples of pooled guinea pig serum. The optimum time of contact was the same as for peptone, about 2 minutes. The results shown in Table VI were obtained with the viscosimetric method. Table VI also shows the influence of the aging of serum on profibrinolysin activation. The maximum was reached in about 3 days and the activity decreased slowly after the 1st week. Between experiments the serum was kept at --20°C.
The following experiment was performed to investigate the effect of hydrolysis of hyaluronic acid on its activating power. Three mg. of hyaluronic acid was incubated at pH 6 and 37.5°C. with the amount of hyaluronidasC known to produce 50 per cent hydrolysis in 30 minutes (as estimated by the turbidimetric method). Samples containing 0.6 rag. hyaluronic acid (or the equiva-lent amounts of hydrolysis products) were collected at definite intervals after the beginning of incubation and tested for profibrinolysin activation with the fibrinogenolytic method. The results shown in Table VII indicate a steady decline in activity while hyaluronic acid is submitted to enzymatic hydrolysis. Viscosimetric data. Hyalurunic acid ffi 0.36 mg./mL serum; interval ffi 2 minutes.
TABLE VII

Influence of Enzymic Hydrolysis of Hyaluroni¢ Acid on Proffodnolysin Act~ealion
Incubation time with hyaluronidue Units/ml. serum Hyaluronic acid was incubated with hyaluronidase at pH 6 and 37.5°C. Samples were collected at stated intervals and added to serum (0.6 rag. per ml.).
This indicates that hyaluronic acid itself and none of its hydrolysis products is responsible for the activation of profibrinolysin. (types I and II), 9 and heparin 1° were active. The results are summarized in Table VIII. 6. Inhibition of the Activation by Heparin.-- Table VIII shows that heparin activates profibrinolysin only up to 0.4 rag. per ml. serum and that this ceases when the concentration of heparin is increased. The possible inhibitory effect of large amounts of heparin on profibrinolysin activation was therefore investigated. Table IX shows that 2 mg. of heparin per ml. can prevent the activation of the profibrinolysin by hyaluronic acid. That heparin inhibits the conversion of the precursor into the active enzyme, i~ shown by the fact 0 Kindly supplied by Dr. Michael Heidelberger. lo Na heparin Lederle that it has no effect on proteolytic activity when added to the euglobulin fraction after precipitation. This is contrary to the findings of Glazko and Ferguson (15) who found heparin to be a protease inhibitor. Heparin inhibits Heparin 0.18 rag.
Unlts/ml. serum, when ~0.
inhibitor Inhibitor ] Inhibitor added to added to ., erum eugk t ulin only the activation by hyaluronic acid and has no effect on fibrinolysin release by streptokinase n or peptone. Toluidine blue, an antagonist of heparin, also prevents the activation of profibrinolysin by hyaluronic acid.
n Kindly supplied by Dr. B. W. Carey of Lederle Laboratories.
7. Negative Results.--No activating effect was found when the following substances were tested: thromboplastin, 12 dicoumarol, starch, 1~ epinephrine hydrochloride, histamine dihydrochloride, acetylcholine chloride.
8.
Conditions o/Activation.--It is well known that the inactive euglobulin precipitated from serum can be activated by chloroform or streptokinase (16, 17, 13) , and in fact streptokinase produces a better activation when added to the euglobulin fraction than when added to whole serum (Table X) . On the other hand peptone and hyaluronic acid fail to induce activation under these conditions. They act only when added to whole serum.
Ratnoff has shown that streptokinase added to heated serum still releases active enzyme (13) . Peptone or hyaluronic acid fails to produce any activation under these conditions. It therefore appears that the activation of profibrinolysin by the agents described in these experiments requires the presence of some serum constituent not precipitated with the euglobulin fraction and destroyed by heating at 56 ° .
DISCUSSION
A physiological kinase system of various tissue cells has been described by Fleisher and Loeb (18) , Astrup and Pertain (19, 20) , Goldhaber, Cornman, and Ormsbee (21) , and the presence of a "cytofibrinokinase" in erythrocytes has been reported by Pertain (22) . The above experiments give further support to the opinion that profibrinolysin can be activated under conditions that are usually assumed to occur in the intact animal.
The activating agents employed in the present study require for their action the presence of some serum constituent which is not precipitated with the euglobulin fraction and which is destroyed at 56°C. That this constituent is not the proenzyme itself is shown by the fact that the euglobulin precipitate and heated serum can still be activated by chloroform or streptokinase. However, the possibility that the protease produced under the conditions described above is not identical with fibrinolysin resulting from chloroform or streptokinase activation cannot be excluded. Pending further investigation, a fibrinokinase is assumed to be the necessary serum constituent.
The mechanism by which the activating agents induce kinase to act on the proenzyme is unknown. One hypothesis under investigation is that the kinase is held inactive by an antikinase and the activating agent acts by liberating it from this combination. The carbohydrate nature of the most potent activators suggests that the hypothetical antikinase may be a carbohydrate itself and can be displaced from its combination with the kinase by the activating agents. Heparin might well compete in this reaction with hyaluronic acid as it does in inhibiting hyaluronidase (23) .
Thrombophstin local Lederle. it Soluble starch Merck.
The results described above permit a new interpretation of some early experiments in which serum was rendered toxic by addition of specific antigen or various non-antigenic substances (24, 25) . The "anaphylatoxin" or "serotoxin" developed under these conditions cannot be histamine or any other simple substance because these substances cannot be released from serum. Futhermore, even if released from whole blood, their concentration would be too low to explain the high toxicity of a few milliliters of serum (26) (27) (28) . The same objection is valid for fibrinolysin itself. It therefore appears that the toxic factor may be a kinase which can induce activation of large amounts of large amounts of fibrinolysin in dvo. This possibility is now under investigation.
The appearance of a protease during anaphylactic and anaphylactoid reaction in dtro suggests that this process may also occur in the intact animal and supplies additional evidence in favor of the enzymatic origin of the toxic products directly responsible for the mechanism of shock.
SUMMARY
Formation of fibrinolysin from its inactive precursor in serum was observed under the following conditions: (a) by adding the specific antigen to serum from sensitized guinea pigs; (b) by mixing normal guinea pig serum with peptone, agar, hyaluronic acid, chondroitinsulfuric acid, glycogen, pneumococcal polysaccharides, and heparin.
Activation of profibrinolysin by these agents differs from chloroform or strcptokinase activation in that it requires the presence of some serum constituent non-precipitable with the euglobulin fraction and destroyed by heating at 56°C.
The bearing of these observations on the mechanism of anaphylactic and anaphylactoid reactions is discussed. The findings reported support the concept that proteolysis is part of the process determining the release of histamine and other toxic products.
It is suggested that the presence of fibrinokinase may be responsible for the toxicity of serum induced in dtro by a number of agents.
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